natgillin/translations-raw huggingface dataset:
Hycamtin 1 mg powder for concentrate for solution for infusion should be reconstituted with 1.1 ml of water for injections to provide 1 mg per ml of topotecan.
Hycamtin 1 mg prašek za koncentrat za raztopino za infundiranje morate rekonstituirati z 1,1 ml vode za injekcije, da dobite raztopino s koncentracijo 1 mg topotekana na ml.
HYCAMTIN 1 mg vials must be reconstituted with 1.1 ml water for injections.
HYCAMTIN 1 mg viale morate rekonstituirati z 1,1 ml vode za injekcije.
HYCAMTIN 4 mg is available in cartons containing 1 vial and 5 vials.
HYCAMTIN 4 mg je na voljo v škatlah z 1 vialo in 5 vialami.
HYCAMTIN 4 mg is supplied in 17 ml type I flint glass vials, together with 20 mm grey butyl rubber stoppers and 20 mm aluminium seals with plastic flip-off caps.
HYCAMTIN 4 mg je na voljo v 17-ml vialah iz kristalnega stekla (tip I), ki so opremljene s 20-mm sivimi zamaški iz butilne gume, zapečatene s 20-mm aluminijasto zaporko s plastičnim pokrovom (flip-off).
Hycamtin 4 mg powder for concentrate for solution for infusion should be reconstituted with 4 ml of water for injections to provide 1 mg per ml of topotecan.
Hycamtin 4 mg prašek za koncentrat za raztopino za infundiranje morate rekonstituirati s 4 ml vode za injekcije, da dobite raztopino s koncentracijo 1 mg topotekana na ml.
HYCAMTIN 4 mg vials must be reconstituted with 4 ml water for injections.
HYCAMTIN 4 mg viale morate rekonstituirati z 4 ml vode za injekcije.
Hycamtin can make people feel tired.
Zdravilo Hycamtin lahko povzroča utrujenost.
Hycamtin can make people feel tired.
Zdravilo Hycamtin lahko povzroči utrujenost.
HYCAMTIN capsules are indicated as monotherapy for the treatment of adult patients with relapsed small cell lung cancer (SCLC) for whom re-treatment with the first-line regimen is not considered appropriate (see section 5.1).
Kapsule HYCAMTIN so indicirane kot monoterapija za zdravljenje odraslih bolnikov z relapsom drobnoceličnega pljučnega raka, pri katerih ponovno zdravljenje s terapijo prve izbire ni primerno (glejte poglavje 5.1).
Hycamtin capsules may be taken with or without food.
Kapsule Hycamtin lahko vzamete s hrano ali brez nje.
Hycamtin capsules must not be opened or crushed.
Kapsul Hycamtin ne smete odpirati ali drobiti.
HYCAMTIN capsules should not be broken or crushed.
Kapsul HYCAMTIN ne smete odpirati ali drobiti.
HYCAMTIN capsules should not be opened or crushed.
Kapsul HYCAMTIN se ne sme odpirati ali drobiti.
Hycamtin comes as a powder for concentrate for solution for intravenous infusion.
Zdravilo Hycamtin je v obliki praška za koncentrat za raztopino za intravensko infundiranje.
Hycamtin helps to destroy tumours.
Zdravilo Hycamtin pomaga uničevati rakave celice.
Hycamtin is available in packs containing 10 capsules of 0.25 mg or 1 mg topotecan.
Zdravilo Hycamtin je na voljo v pakiranjih, ki vsebujejo po 10 kapsul z 0,25 mg ali 1 mg topotekana.
HYCAMTIN is contraindicated in patients who
Zdravilo HYCAMTIN je kontraindicirano pri bolnikih oz. bolnicah
HYCAMTIN is contraindicated in patients who
Zdravilo HYCAMTIN je kontraindicirano pri:
Hycamtin is used to treat:
Zdravilo Hycamtin se uporablja pri zdravljenju:
Hycamtin may harm a baby conceived before, during or soon after treatment.
Zdravilo Hycamtin lahko škoduje otroku, spočetemu pred zdravljenjem, med zdravljenjem ali kmalu po njem.
Hycamtin with food and drink
Zdravilo Hycamtin skupaj s hrano in pijačo
hydrobromide
(0,94; 1,33)
hydrobromide
1 mcg/kg/ teden
hydrocele
hidrokela
Hydrocephalus has also been reported, possibly precipitated by arachnoiditis.
Poročajo tudi o hidrocefaliji, ki jo verjetno izzove aranhnitis.
Hydrochloric acid
natrijev klorid
Hydrochloric acid (0.04 M)
klorovodikova kislina (0,04 M)
Hydrochloric acid (E507) (for pH adjustment) Water for injections
klorovodikova kislina (E507) (za uravnanje pH) voda za injekcije
Hydrochloric acid (E507) (for pH adjustment) Water for injections
klorovodikova kislina (E507) (za uravnavanje pH) voda za injekcije
Hydrochloric acid (E507) (for pH-adjustment) Water for injections
Klorovodikova kislina (E507) (za uravnavanje pH) Voda za injekcije
Hydrochloric acid (E507) Water for injections
klorovodikova kislina (E507) voda za injekcije
Hydrochloric acid (for pH adjustment) Sodium hydroxide (for pH adjustment)
Klorovodikova kislina (za prilagoditev pH) Natrijev hidroksid (za prilagoditev pH)
Hydrochloric acid (for pH adjustment) Sodium hydroxide (for pH adjustment) Water for injections
cinkov acetat klorovodikova kislina (za uravnavanje pH) natrijev hidroksid (za uravnavanje pH) voda za injekcije
Hydrochloric acid (for pH adjustment) Sodium hydroxide (for pH adjustment) Water for injections
Klorovodikova kislina (za uravnavanje pH) Natrijev hidroksid (za uravnavnje pH) Voda za injekcije
Hydrochloric acid (for pH-adjustment)
Klorovodikova kislina (za uravnavanje pH)
Hydrochloric acid (for pH-adjustment) Sodium hydroxide (for pH-adjustment)
Klorovodikova kislina (za uravnavanje pH-vrednosti) Natrijev hidroksid (za uravnavanje pH-vrednosti)
Hydrochloric acid (for pH-adjustment) Sodium hydroxide (for pH-adjustment)
voda za injekcije klorovodikova kislina (za uravnavanje pH) natrijev hidroksid (za uravnavanje pH)
Hydrochloric acid (to adjust pH) Sodium hydroxide (to adjust pH)
voda za injekcije klorovodikova kislina (za uravnavanje pH) natrijev hidroksid (za uravnavanje pH)
Hydrochloric acid 0.1 N. Water for injections.
klorovodikova kislina 0,1 M. voda za injekcije.
Hydrochloric acid 3.7% (to adjust pH) and/or sodium hydroxide (to adjust pH) Water for injections
klorovodikova kislina 3,7 % (za prilagoditev pH) in/ali natrijev hidroksid (za prilagoditev pH) voda za injekcije
Hydrochloric acid 30 % Water for injections
30 % klorovodikova kislina voda za injekcije
Hydrochloric acid and sodium hydroxide (for pH adjustment).
Klorovodikova kislina in natrijev hidroksid (za uravnavanje pH).
Hydrochloric acid and sodium hydroxide may be used to adjust pH to 7.0 – 7.8.
Za uravnavanje pH na 7,0-7,8 sta morda bila uporabljena klorovodikova kislina in natrijev hidroksid.
Hydrochloric acid and sodium hydroxide may be used to adjust pH to 7.0-7.8.
Za uravnavanje pH na 7,0-7,8 sta morda bila uporabljena klorovodikova kislina in natrijev hidroksid.
Hydrochloric acid and sodium hydroxide maybe used to adjust pH to 7.0 – 7.8.
Za uravnavanje pH na 7,0-7,8 sta morda bila uporabljena klorovodikova kislina in natrijev hidroksid.
Hydrochloric acid and/or sodium hydroxide (pH adjustment)
dinatrijev edetat klorovodikova kislina in/ali natrijev hidroksid (pH uravnavanje)
Hydrochloric acid and/or sodium hydroxide (to adjust pH) Purified water
natrijev klorid tiloksapol klorovodikova kislina in/ali natrijev hidroksid (za prilagoditev pH) prečiščena voda
Hydrochloric acid concentrated (for pH adjustment)
koncentrirana klorovodikova kislina (za uravnavanje pH)
Hydrochloric acid Water for injections
klorovodikova kislina voda za injekcije
Hydrochloric acid, concentrated
klorovodikova kislina
Hydrochloric acid, concentrated
klorovodikova kislina, koncentrirana
Hydrochloric acid, concentrated Artificial cherry flavour Peppermint oil
koncentrirana klorovodikova kislina umetna aroma češnje
hydrochloric acid, sodium hydroxide.
klorovodikovo kislino natrijev hidroksid.
Hydrochloric acid7
Solna kislina 7
hydrochloride/Efavirenz
klorid/efavirenz
hydrochlorothiazide (or any combination with hydrochlorothiazide)
hidroklorotiazid (ali kombinacije zdravil, ki vsebujejo hidroklorotiazid)
hydrochlorothiazide (or any combination with hydrochlorothiazide)
hidroklorotiazid (ali kombinacije zdravil, ki vsebujejo hidroklorotiazid),
hydrochlorothiazide alone
hidroklorotiazida samega
Hydrochlorothiazide contained in this medicinal product could produce a positive analytic result in an anti-doping test.
Zaradi hidroklorotiazida, ki ga zdravilo vsebuje, je lahko test za ugotavljanje jemanja nedovoljenih poživil pozitiven.
Hydrochlorothiazide is 68 % protein- bound in the plasma, and its apparent volume of distribution is 0.83-1.14 l/kg.
Na plazemske beljakovine se veže približno 68 % hidroklorotiazida; njegov porazdelitveni volumen je 0,83 do 1,14 l/kg.
Hydrochlorothiazide is 68% protein- bound in the plasma, and its apparent volume of distribution is 0.83-1.14 l/kg.
Na plazemske beljakovine se veže približno 68 % hidroklorotiazida; njegov porazdelitveni volumen je 0,83 do 1,14 l/kg.
Hydrochlorothiazide is a diuretic, which is another type of treatment for hypertension.
Hidroklorotiazid je diuretik, kar je druga vrsta zdravila za zdravljenje zvišanega krvnega tlaka.
Hydrochlorothiazide is eliminated predominantly as unchanged compound.
Hidroklorotiazid se večinoma izloča v obliki nespremenjene učinkovine.
Hydrochlorothiazide may cause or exacerbate hypovolaemia which could lead to electrolyte imbalance (see section 4.4).
Hidriklorotiazid lahko povzroči ali poslabša hipovolemijo, kar lahko privede do neravnovesja elektrolitov (glejte poglavje 4.4).
Hydrochlorothiazide:
Hidroklorotiazid
Hydrochlorothiazide: Following oral administration of Kinzalkomb peak concentrations of hydrochlorothiazide are reached in approximately 1.0 – 3.0 hours after dosing.
Hidroklorotiazid: Po peroralnem dajanju zdravila Kinzalkomb doseže hidroklorotiazid največjo koncentracijo v plazmi približno v 1,0 do 3,0 urah.
Hydrochlorothiazide: Following oral administration of MicardisPlus peak concentrations of hydrochlorothiazide are reached in approximately 1.0 – 3.0 hours after dosing.
Hidroklorotiazid: Po peroralnem dajanju zdravila MicardisPlus doseže hidroklorotiazid največjo koncentracijo v plazmi približno v 1,0 do 3,0 urah.
Hydrochlorothiazide: Following oral administration of PritorPlus peak concentrations of hydrochlorothiazide are reached in approximately 1.0 – 3.0 hours after dosing.
Hidroklorotiazid: Po peroralnem dajanju zdravila PritorPlus doseže hidroklorotiazid največjo koncentracijo v plazmi približno v 1,0 do 3,0 urah.
Hydrochlorothiazide: Following oral administration of telmisartan/hydrochlorothiazide, peak concentrations of hydrochlorothiazide are reached in approximately 1.0-3.0 hours after dosing.
Hidroklorotiazid: Po peroralnem dajanju zdravila Actelsar HCT doseže hidroklorotiazid največjo koncentracijo v plazmi približno v 1,0 do 3,0°urah.
Hydrochlorothiazide: Following oral administration of Tolucombi peak concentrations of hydrochlorothiazide are reached in approximately 1.0 – 3.0 hours after dosing.
Hidroklorotiazid: Po peroralnem dajanju zdravila Tolucombi doseže hidroklorotiazid največjo koncentracijo v plazmi približno v 1,0 do 3,0 urah.
Hydrocodone
Hidrokodon (kot fiksni
Hydrocodone (as given in a fixed-dose hydrocodone/ paracetamol)
Hidrokodon (kot fiksni
hydrocodone dose by 50%
Razmisliti je treba o 50 % zmanjšanju
hydrocodone/
hidrokodon/par
Hydrocortisone aceponate 1.11 mg/ml
Hidrokortizon aceponat 1,11 mg/ml
Hydrocortisone aceponate 1.11 mg/ml, Miconazole as nitrate 15.1 mg/ml, Gentamicin as sulphate 1,505 IU/ml.
Hidrokortizon aceponat 1.11 mg/ml Mikonazol v obliki nitrata 15.1 mg/ml Gentamicin v obliki sulfata 1,505 IU/ml
Hydrocortisone aceponate belongs to the diesters class of the glucocorticosteroids.
Hidrokortizon aceponat spada v diestre iz razreda glukokortikosteroidov.
Hydrocortisone aceponate belongs to the diesters’ class of glucocorticosteroids.
Hidrokortizon aceponat spada v diestersko skupino glukokortikosteroidov.
Hydrocortisone aceponate is a dermocorticoid with a potent intrinsic glucocorticoid activity which means a relief of both inflammation and pruritus leading to a quick improvement of skin lesions observed in case of inflammatory and pruritic dermatosis.
Hidrokortizon aceponat je dermokortikoid z močnim intrinzičnim glukokortikoidnim delovanjem, ki pomeni olajšanje tako vnetja kot pruritisa, in pripelje do hitrega celjenje kožnih poškodb, ki so zaznavne pri vnetljivih in pruritičnih dermatozah.
Hydrocortisone aceponate thus accumulates in the dog’s skin allowing local efficacy at low dosage.
Na ta način se hidrokortizon aceponat v koži psa akumulira in pri nizkih odmerkih omogoča lokalno učinkovitost.
Hydrocortisone acetate 1%
Hidrokortizonacetat 1
Hydrocortisone acetate 1% (N=185)
Hidrokortizonacetat 1% (N=185)
hydrocortisone and prednisolone (corticosteroids) used to treat diseases that involve inflammation like asthma and arthritis
hidrokortizon in prednizolon (kortikosteroida), ki ju uporabljamo za zdravljenje bolezni, ki vključujejo vnetja, kot sta astma in artritis.
Hydrocortisone is a class II active substance according to the biopharmaceutical classification system (BCS) with a high intestinal permeability and a low dissolution rate, especially at higher doses.
Hidrokortizon je zdravilna učinkovina skupine II po sistemu biofarmacevtske klasifikacije (BCS) z visoko prepustnostjo skozi črevesje in nizko stopnjo raztapljanja, zlasti pri večjih odmerkih.
Hydrocortisone is given as replacement therapy aimed at restoring normal cortisol levels.
Hidrokortizon se daje kot nadomestno zdravljenje za ponovno vzpostavitev normalne ravni kortizola.
Hydrocortisone replaces the natural cortisol that is missing in patients with adrenal insufficiency.
Hidrokortizon nadomešča naravni kortizol, ki ga bolnikom z adrenalno insuficienco primanjkuje.
Hydrocortisone should not be used as it has not been effective in reducing rates of IRR.
Hidrokortizona se ne sme uporabiti, ker ni učinkovito zmanjšal deleža reakcij, povezanih z infuzijo.
Hydrolysis takes place mainly in the liver; the rate of hydrolysis in human plasma is very slow.
Hidroliza v glavnem poteka v jetrih, hidroliza v človeški plazmi pa je zelo počasna.
hydrolytic glass vials type I (EP) with butyl stopper (EP) and aluminium seal
viale iz hidrolitičnega stekla tipa I (EP) z butilnim zamaškom (EP) in alumijsko zaporko
hydrolytic glass vials type II (EP) with butyl stopper (EP) and aluminium seal
viale iz hidrolitičnega stekla tipa II (EP) z butilnim zamaškom (EP) in alumijsko zaporko
Hydronephrosis
hidronefroza
Hydronephrosis Renal failure Urine abnormality
hidronefroza ledvična odpoved nenormalnosti urina
Hydronephrosis Renal failure Urine abnormality
motnje pozornosti parestezije
Hydronephrosis, Urinary incontinence, Haematuria, Nocturia, Blood creatinine increased
hidronefroza, urinarna inkontinenca, hematurija, nikturija, zvišan kreatinin v krvi
Hydroquinidine
področjih (odmerek
hydroxide antacids nor famotidine
hidroksidni antacidi niti
hydroxide-simethicone
hidroksidni-simetikonijev
Hydroxocobalamin has not been evaluated for carcinogenic potential.
Kancerogenega potenciala hidroksokobalamina niso ocenjevali.
Hydroxocobalamin reduced whole blood cyanide concentrations from about 120 nmol/mL to 30-40 nmol/mL by the end of the infusion compared with 70 nmol/mL in dogs receiving sodium chloride 9 mg/mL alone.
Hidroksokobalamin je ob koncu infundiranja zmanjšal celotno koncentracijo cianida v krvi s približno 120 nmol/ml na 30–40 nmol/ml, pri psih, ki so prejemali samo 9 mg/ml natrijevega klorida, pa je koncentracijo zmanjšal na 70 nmol/ml.
Hydroxy Methyl Glutaryl Coenzyme A (HMG CoA) reductase inhibitors
Zaviralci hidroksimetilglutaril koencim A (HMG CoA) reduktaze
Hydroxy methyl glutaryl coenzyme A reductase inhibitors
Zaviralci hidroksimetilglutaril koencim A reduktaze
Hydroxy- dabrafenib terminal half-life parallels that of parent with a half-life of 10 hrs while the carboxy- and desmethyl-metabolites exhibited longer half-lives (21-22 hours).
Terminalni razpolovni čas hidroksidabrafeniba je podoben razpolovnemu času matične učinkovine in znaša 10 ur, razpolovna časa karboksi- in dezmetilnega presnovka pa sta daljša (21 do 22 ur).
Hydroxy- lenalidomide and N-acetyl-lenalidomide represent 4.59% and 1.83% of the excreted dose, respectively.
Hidroksi- lenalidomid predstavlja 4,59 % in N-acetil-lenalidomid predstavlja 1,83 % izločenega odmerka.
Hydroxy-Δ5-C27-steroid oxidoreductase deficiency or Δ4-3-Oxosteroid-5β-reductase deficiency and no dose recommendation can be given.
3β-hidroksi-Δ5-C27-steroid-oksidoreduktaze ali pomanjkanja Δ4-3-oksosteroid-5β-reduktaze ni, zato ni mogoče navesti priporočil za odmerjanje.
Hydroxybupropion: AUC: +--
hidroksibupropion:
Hydroxycarbamide administered to male rats at 60 mg/kg b.w./day (about double the recommended usual maximum dose in humans) produced testicular atrophy, decreased spermatogenesis and significantly reduced their ability to impregnate females.
Hidroksikarbamid, ki so ga dali moškim podganam v višini 60 mg/kg TM/dan (približno dvakratni odmerek priporočenega najvišjega odmerka za ljudi), je povzročil atrofijo mod, znižanje spermatogeneze in signifikantno zmanjšano sposobnost za oploditev samic.
Hydroxycarbamide at 30, 100 and 300 µM is not metabolised in vitro by cytochrome P450s of human liver microsomes.
Hidroksikarbamid se pri 30, 100 in 300 µM s sistemom citokroma P450 jetrnih mikrosomov in vitro ne metabolizira.
Hydroxyethylcellulose
Hidroksietilceluloza
Hydroxypropyl Cellulose Glycerol
Hidroksipropilceluloza Glicerol
hydroxypropyl methylcellulose aspartame (E951)
hipromelozo, aspartam (E951),
Hydroxypropylbetadex Ethanol (96 percent) Purified water
hidroksipropilbetadeks etanol, 96 odstotni prečiščena voda
Hydroxypropylcellulose
mukec hidroksipropilceluloza
Hydroxypropylcellulose (E 463) Sodium laurilsulfate (E 487) Sucrose
hidroksipropilceluloza (E 463) natrijev lavrilsulfat (E 487) saharoza
hydroxypropylcellulose hypromellose propylene glycol titanium dioxide (E 171)
hidroksipropilceluloza hipromeloza propilenglikol titanov dioksid (E 171)
hydroxypropylcellulose hypromellose propylene glycol titanium dioxide (E 171) ferric oxide red (E 172) ferric oxide yellow (E 172)
hidroksipropilceluloza hipromeloza propilenglikol titanov dioksid (E 171) rdeči železov oksid (E 172) rumeni železov oksid (E 172)
hydroxypropylcellulose hypromellose propylene glycol titanium dioxide (E 171) ferric oxide yellow (E 172)
hidroksipropilceluloza hipromeloza propilenglikol titanov dioksid (E 171) rumeni železov oksid (E 172)
Hyper-
tesnoba
Hyper- pigmentation
Hiper- pigmentacija
Hyper- sensitivity (including angioedema, anaphylactic reaction, and anaphylactoid reaction)
preobčutljivost (vključno z angioedemom, anafilaktično reakcijo in anafilaktoidno reakcijo)
Hyper- sensitivity reaction
preobčutljivostn e reakcije
Hyper- sensitivity reactions
Preobčutljivostn e reakcije
Hyper-active thyroid gland (may show in your blood tests)
preveč dejavna žleza ščitnica (to se lahko pokaže pri preiskavah krvi)
Hyper-CVAD regimen: CP 300 mg/ m2 i.v. (3 h, q 12 h), days 1-3;
hyper-CVAD shema: CP 300 mg/m2 i.v. (3 ure, na 12 ur), 1.-3. dan;
Hyper-CVAD regimen: CP 300 mg/m2 i.v. (3 h, q 12 h), days 1-3;
hyper-CVAD shema: CP 300 mg/m2 i.v. (3 ure, na 12 ur), 1.-3. dan;
Hyper-CVAD regimen: CP 300 mg/m2 i.v. (3 h, q 12 h), days 1-3;
hyper-CVAD shema: CP 300 mg/m² i.v. (3 ure, na 12 ur), 1.-3. dan;
Hyper-sensitivity disorder
preobčutljivost
Hyper-tension
hipertenzija
hyperactivity (excessive restlessness and movement) weakness beginning in the hands and feet and moving up towards the trunk of the body
hiperaktivnost (povečan nemir in prekomerno gibanje), šibkost, ki se začne v dlaneh in stopalih in se širi navzgor proti trupu.
hyperactivity (excessive restlessness and movement) weakness beginning in the hands and feet and moving up towards the trunk of the body.
hiperaktivnost (pretiran nemir in gibanje) oslabelost, ki se začne v rokah in stopalih in se širi navzgor proti trupu
hyperactivity (excessive restlessness and movement) weakness beginning in the hands and feet and moving up towards the trunk of the body.
hiperaktivnost (pretiran nemir in gibanje) oslabelost, ki se začne v rokah in stopalih in se širi navzgor proti trupu.
Hyperactivity (high level of activity, restlessness)
hiperaktivnost (povečana stopnja aktivnosti, nemir) agresivnost
Hyperacusis
hiperakuza
hyperaemia
očesna hiperemija
hyperaemia,
gledanju,
hyperaemia,
motnje šarenice,
hyperaemia,
očesna hiperemija,
hyperaemia,
zapora mrežnične
Hyperaemiae, hypotension
hiperemijae, hipotenzija
Hyperaesthe
nevropatija
hyperaesthesia (abnormal increase in sensitivity to stimuli of the senses)
hiperestezija (nenormalno povečanje občutljivosti na čutne spodbude)
hyperaesthesia, tremor
hiperstezija, tremor
hyperammonaemia due to isovaleric acidaemia.
hiperamoniemije zaradi izovalerične acidemije;
hyperammonaemia due to methymalonic acidaemia. hyperammonaemia due to propionic acidaemia.
hiperamoniemije zaradi metilmalonične acidemije; hiperamoniemije zaradi propionske acidemije.
Hyperammonaemia may be due to the lack of a specific liver enzyme N- acetylglutamate synthase.
Hiperamoniemija lahko nastane zaradi pomanjkanja določenega jetrnega encima, N-acetilglutamat-sintaze.
hyperargininaemia; ornithine translocase deficiency (hyperornithinaemia-hyperammonaemia homocitrullinuria (HHH) syndrome).
hiperargininemija; pomanjkanje ornitin translokaze (sindrom hiperornitinemija-hiperamonemija-homocitrulinurija (sindrom HHH)).
Hyperbilirubin- aemia, alanine aminotransferase increased, aspartate aminotransferase increased
hiperbilirubinemija, povečana alanin- aminotransferaza, povečana aspartat- aminotransferaza
Hyperbilirubin-aemi a, alanine aminotransferase increased, aspartate aminotransferase increased
hiperbilirubinemija, povečana alanin- aminotransferaza, povečana aspartat- aminotransferaza
Hyperbilirubin-aemia
hiperbilirubinemija
Hyperbilirubinaem ia, Liver function test abnormalities
hiperbilirubinemija
Hyperbilirubinaemia (including increased conjugated bilirubin, increased unconjugated blood bilirubin, increased blood bilirubin)
hiperbilirubinemija (vključno z zvišano koncentracijo konjugiranega bilirubina, zvišano koncentracijo nekonjugiranega bilirubina v krvi, zvišano koncentracijo bilirubina v krvi)
hyperbilirubinaemia (increased levels of bilirubin in the blood)
hiperbilirubinemija (zvišanje vrednosti bilirubina v krvi)
Hyperbilirubinaemia Gamma- glutamyltransferase increased
hiperbilirubinemija, povečana vrednost gama-glutamiltransferaze
Hyperbilirubinaemia is frequent with this
Zaradi pogoste hiperbilirubinemije je
Hyperbilirubinaemia*, Protein analyses abnormal*, Weight decreased, Weight increased
hiperbilirubinemija*, nenormalni izvidi analiz proteinov, zmanjšana telesna masa, zvečana telesna masa
Hyperbilirubinaemia*, Protein analyses abnormal*, Weight increased, Blood test abnormal*, C-reactive protein increased
hiperbilirubinemija*, nenormalni izvidi analiz proteinov*, zvečana telesna masa, nenormalni izvidi krvnih preiskav*, zvišana koncentracija C-reaktivnega proteina
Hyperbilirubinaemia*, Protein analyses abnormal*, Weight increased, Blood test abnormal*,C-reactive protein increased
hiperbilirubinemija*, nenormalni izvidi analiz proteinov*, zvečana telesna masa, nenormalni izvidi krvnih preiskav*, zvišana koncentracija C-reaktivnega proteina
Hyperbilirubinaemia, Blood alkaline phosphatase (ALKP) increased
hiperbilirubinemija, zvečana vrednost alkalne- fosfataze v krvi (ALKP)
Hyperbilirubinaemia, gamma- glutamyltransferase increased
hiperbilirubinemija, zvišanje gama- glutamiltransferaze
Hyperbilirubinaemia, hepatitis, jaundice
hiperbilirubinemija, hepatitis, ikterus
Hyperbilirubinaemia, hepatotoxicity (see section 4.4).
hiperbilirubinemija, hepatotoksičnost (glejte poglavje 4,4)
Hyperbilirubine- mia, Liver function test abnormalities
hiperbilirubinem ija, nenormalni testi jetrne funkcije
Hyperbilirubinemia* (Grade 3 = 1%),
Hiperbilirubinemija* (stopnje 3 = 1 %),
hyperbilirubinemia, cholestasis, hepatitis hepatic injury, hepatic failure
hiperbilirubinemija, holestaza, hepatitis, jetrna poškodba, jetrna odpoved
hyperbilirubinemia, cholestasis, hepatitis hepatic injury, hepatic failure†
hiperbilirubinemija, holestaza, hepatitis poškodba jeter, odpoved jeter
hyperbilirubinemia, cholestasis, hepatitis hepatic injury, hepatic failure†
hiperbilirubinemija, holestaza, hepatitis, jetrna poškodba, jetrna odpoved
hyperbilirubinemia, cholestasis, hepatitis hepatic injury, hepatic failure†
zvišanje vrednosti jetrnih encimov, hiperbilirubinemija, holestaza, hepatitis poškodba jeter, odpoved jeter
hyperbilirubinemia, cholestasis, hepatitis, hepatic injury, hepatic failure†
hiperbilirubinemija, holestaza, hepatitis jetrna poškodba, jetrna odpoved
hyperbilirubinemia, cholestasis, hepatitis, hepatic injury, hepatic failure†
Hiperbilirubinemija, holestaza, hepatitis, poškodba jeter, jetrna odpoved